The French Muscular Dystrophy Association (AFM-Téléthon) is composed of patients and their families who are affected by a genetic, rare, progressive and severely disabling illness: neuromuscular diseases. In order to fight those diseases, AFM-Téléthon chose to initiate innovative actions and a strategy of general interest that benefits all rare diseases and all persons with disabilities.

Illustration for category: Values


The values of AFM-Téléthon are those held by the patients and their parents who are determined to do everything it takes to conquer the disease.
Illustration for category: Cure mission

Cure mission

There are about 200 neuromuscular diseases against which AFM-Téléthon fights. Most of them are genetic and rare. To cure them, AFM-Téléthon supports the development of innovative therapies for rare diseases.
Illustration for category: Care mission

Care mission

Neuromuscular diseases are progressive and severely disabling. AFM-Téléthon develops innovative programs to improve quality healthcare and patients’ autonomy. Patients need to be able to access quality healthcare and to live like everyone else, despite their handicap.